English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Health-related quality of life (HRQOL) is increasingly assessed to understand the effects of cancer and cancer-related interventions. At the macro level, monitoring HRQOL in the population and in cancer survivors may be important to track progress against cancer and evaluate the outcome of policies and programs. At the meso level, where most research, to date, has been focused, HRQOL data may be used in descriptive and analytic studies to understand the impact of cancer, patterns of care, and effects of interventions for cancer prevention, treatment, and continuing care. At the micro level, HRQOL data can inform individual patient and clinician decision making. Current data show that validated and commonly used HRQOL questionnaires are not interchangeable. Consequently, in determining which HRQOL measures are most appropriate for a given application, it is especially important to carefully consider both the study hypotheses and patient population. Future progress at all levels requires better understanding of the meaning and interpretation of HRQOL scores.

Assessing Cancer-Related Quality of Life Across a Spectrum of Applications